𝔖 Bobbio Scriptorium
✦   LIBER   ✦

5-Fluorouracil–induced small bowel toxicity in patients with colorectal carcinoma

✍ Scribed by Jacob Lokich

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
45 KB
Volume
88
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5-Fluorouracil-induced small bowel toxic
5-Fluorouracil-induced small bowel toxicity in patients with colorectal carcinoma
✍ Farid Fata; Ilan G. Ron; Nancy Kemeny; Eileen O'Reilly; David Klimstra; David P. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB 👁 2 views

## BACKGROUND. Diarrhea and oral mucositis are the most frequently reported gastrointestinal side effects caused by 5-fluorouracil (5-FU). Diarrhea may be severe in 10 -30% of patients and is schedule-dependent. 5-FU-induced gastrointestinal toxicity predominantly affects the upper and the lower g

Comparison of 5-fluorouracil with 5-fluo
Comparison of 5-fluorouracil with 5-fluorouracil, cyclophosphamide, and methotrexate in metastatic colorectal carcinoma
✍ Frederick Richards II; Thomas L. Pajak; Miles R. Cooper; Charles L. Spurr 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB

Thirty-eight patients with metastatic colorecal carcinoma were treated with 5-fluorouracil (5-FU), and 38 patients were treated with the combination of 5-FU, cyclophosphamide, and methotrexate. In terms of percent response, response duration, and survival there was no apparent difference between the

A comprehensive review of 5-fluorouracil
A comprehensive review of 5-fluorouracil and leucovorin in patients with metastatic colorectal carcinoma
✍ David Machover 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views

## Background: Colorectal carcinoma is the third leading cause of cancer-related death. the primary treatment for patients with metastatic colorectal carcinoma is systemic chemotherapy with 5-fluorouracil (5-fu) and leucovorin (lv), a biomodulator of 5-fu that has been shown to enhance its activity

Hypocalcemia associated with 5-fluoroura
Hypocalcemia associated with 5-fluorouracil and low dose leucovorin in patients with advanced colorectal or gastric carcinomas
✍ Yuichiro Kido; Takeshi Okamura; Morimasa Tomikawa; Manabu Yamamoto; Morio Shirai 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 367 KB 👁 1 views

## BACKGROUND. The biochemical modulation of 5-fluorouracil (5-FU) by leucovorin (Lv) has demonstrated significantly increased response rates in comparison with the use of 5-FU alone in patients with advanced colorectal carcinoma. However, the higher response rate of LV/5-FU may occur at the expen